Funded Research

Understanding and exploiting the role of phagocyte mechanobiology in anti-tumor immunity

Year

2024

Host institution

Simon Fraser University

Research location

Simon Fraser University – Burnaby Campus

Partner

Supervisor

CO-lEad

Cancer is the leading cause of mortality in British Columbia. Whereas the immune system has long been recognized as an effective protection against infections, recent breakthroughs have demonstrated that the immune system also has the capacity to control cancer progression. Thus, cancer immunotherapies are being developed as a new type of treatment that acts by boosting the natural capacities of the immune system and directing it to destroy tumors. Amongst the different types of cells composing the immune system, professional phagocytes have the unique capacity to eliminate cancer cells by engulfing and digesting them. Subsequently, they are able to activate other immune cells, called lymphocytes, to mount an immune response specifically directed against the tumor. However, new evidence suggests that mechanical cues and physical constraints prevent phagocytes from using their anti-tumor potential. The goal of this project is to understand how phagocytes sense, respond and utilize mechanical forces to overcome physical constraints, with the aim to harness these mechanisms to develop more effective cancer immunotherapies.

Building research careers

Since 2001, we’ve supported over 3,000 BC health researchers to launch programs, drive innovations, and attract millions in new research investment.

View all funded research

Funded research